Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer
about
Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanismsRhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier functioniRhoms; Its Functions and Essential Roles.Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16.Rhomboid proteins: a role in keratinocyte proliferation and cancer.Insights into desmosome biology from inherited human skin disease and cardiocutaneous syndromes.Candidate susceptibility variants for esophageal squamous cell carcinoma.Genetic deletion of amphiregulin restores the normal skin phenotype in a mouse model of the human skin disease tylosisDeletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses.Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation.Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice.Tissue-specific role of RHBDF2 in cutaneous wound healing and hyperproliferative skin disease.iRhom2 (Uncv) mutation blocks bulge stem cells assuming the fate of hair follicle.FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex
P2860
Q26784445-0730FC45-BED2-461F-ABE2-46686D113521Q33694413-3E0BA106-6D90-449F-8017-2E5E2EFBCE78Q33704501-303DF1AC-292A-4879-9829-2237953776B0Q33947954-46B7690D-32E1-4029-975C-39553E430642Q36640392-31C0EC0B-CD7D-4FD4-AC19-DD62873E5A4EQ37622403-E5BF62A0-8630-4CD6-9AD3-159F74B31D76Q38069466-213B3F68-BE48-4097-9093-AAD7DAE66D2BQ38205032-EFEF03A6-2E55-49D2-BEA2-17E2F410F145Q38376072-D606CF75-4D17-47CE-AB17-610CDD9074B5Q38706195-B23F8679-E4E6-4910-9B99-C0DBA4578017Q38822173-834C3104-8B99-4350-A2FE-144012F13E45Q38852399-30B03D4B-4FA2-4927-A1D2-2D6C1E84CCBFQ40080379-CD32B730-8860-44D8-A014-123074A378BCQ41936018-DCC932D2-9634-449F-9E24-71ABE0D25B50Q42615354-0748B02A-92C1-44CE-8452-149A8665EFB2Q46799374-477EF19C-99BA-4D4E-B3CE-2DAFABAB635FQ51653461-A4C90DEC-B253-456E-8CC1-BB6304ADAB15Q56889930-A40FE05D-1149-4F87-B5DA-8AD416E249A3
P2860
Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2012
@uk
name
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@en
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@nl
type
label
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@en
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@nl
prefLabel
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@en
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@nl
P2093
P2860
P1433
P1476
Analysis of a Finnish family c ...... tylosis with esophageal cancer
@en
P2093
Kristiina Aittomäki
Pia Vahteristo
Silva Saarinen
Tuula Kiviluoto
Virpi Launonen
P2860
P2888
P304
P356
10.1007/S10689-012-9532-8
P577
2012-09-01T00:00:00Z